ABSTRACT
Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizinglocal drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. Thedevice is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatmentregimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study wasto describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment.Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selectedfor the study. The dogs were randomly allocated to two groups with five and six animals, and each group received thechemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were madewhenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the MadisonWisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia,using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions werecompared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1);immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). Thearithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean ofSBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC...(AU)
Subject(s)
Animals , Dogs , Lymphoma/veterinary , Pharmaceutical Preparations/administration & dosage , Drug Therapy/veterinary , Dogs , Catheters/veterinaryABSTRACT
Background: Vascular access port (VAP) was developed for the administration of chemotherapeutic agents, minimizinglocal drug reactions and complications associated with migration of peripheral venous catheter (PVC) in humans. Thedevice is widely used in human oncology and has gained importance in veterinary oncology, especially in long treatmentregimens, as in the case of canine lymphoma. VAP favors therapy and the animals life quality. The aim of this study wasto describe the use of VAP in dogs, comparing to PVC access, during canine lymphoma chemotherapeutic treatment.Materials, Methods & Results: Eleven dogs with multicentric lymphoma which required chemotherapy were selectedfor the study. The dogs were randomly allocated to two groups with five and six animals, and each group received thechemotherapy protocol through the PVC (n= 5) or VAP (n= 6). For the sake of standardization, assessments were madewhenever the dogs received vincristine sulfate, despite the use of the infusion system in all sessions of the MadisonWisconsin protocol. A VAP was implanted into the right external jugular vein of six dogs under inhalational anesthesia,using the Seldinger technique. Systolic blood pressure (SBP) levels and handling time during chemotherapy sessions werecompared in both groups in three time periods during the procedures: 10 min after arrival to each chemotherapy (P1);immediately after placement of the PVC or puncture of the VAP reservoir (P2); and at the end of chemotherapy (P3). Thearithmetic mean of five consecutive assessments was used in each time period. In the chemotherapy sessions, the mean ofSBP variation decreased statistically significant in the VAP group compared to PVC group. SBP decreased from P1 to P2and from P1 to P3 in all sessions (S1, S2, and S3) in the VAP group, and increased in the PVC...
Subject(s)
Animals , Dogs , Lymphoma/veterinary , Pharmaceutical Preparations/administration & dosage , Drug Therapy/veterinary , Catheters/veterinary , DogsABSTRACT
OBJECTIVE: To investigate Port-A-Cath (PAC)-related thrombosis and postthrombotic syndrome (PTS) in children with cancer. STUDY DESIGN: The study population was a consecutive cohort of children diagnosed with cancer and a PAC implanted at diagnosis. Children were evaluated for the presence of PAC-related thrombosis by magnetic resonance venography and the presence of congenital prothrombotic risk factors and PTS. RESULTS: A total of 114 children (median age, 6.04 years) were included. Of these children, 48 (42%) were treated for solid tumors and 66 (58%) were treated for hematopoietic tumors, including 38 for acute lymphoblastic leukemia. At the time of magnetic resonance venography, 42 children (37%) had the PAC still in place, and 72 (63%) had the PAC removed. Overall, PACs were in place for a total of 324.92 PAC-years. PAC-related thrombosis was detected in 45 children (39.5%) with a current or previous PAC. Of these, 21 (47%) had a solid tumor, 14 (31%) had acute lymphoblastic leukemia, and 10 (22%) had another hematopoietic tumor. Younger age at diagnosis, female sex, duration of PAC use, and left-side PAC placement were independently associated with an increased risk of thrombosis, whereas asparaginase therapy and the presence of inherited prothrombotic risk factors were not. Mild PTS (ie, presence of prominent collateral vessels in the skin) was present in 5.6% of the children. CONCLUSION: PAC-related thrombosis is common in pediatric oncology patients. In some children, thrombotic complications can lead to the development of PTS.
Subject(s)
Postthrombotic Syndrome/diagnosis , Thrombosis/diagnosis , Vascular Access Devices/adverse effects , Adolescent , Age Factors , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Magnetic Resonance Imaging , Male , Neoplasms/complications , Neoplasms/therapy , Phlebography , Postthrombotic Syndrome/etiology , Risk Factors , Thrombosis/etiologyABSTRACT
Este trabalho buscou implementar uma sistematização da assistência de enfermagem nos pacientes portadores de cateter venoso central de longa permanência, em especial, o cateter venoso central totalmente implantado (CVC-TI) em rede privada especializada, a qual ainda não dispõe de tais condutas. Baseou-se se em livros específicos em área oncológica, publicados até a presente data e que contribuíram para a realização do processo de normatização de condutas. O objetivo geral do estudo foi minimizar as complicações provenientes da inserção e manutenção de cateteres de longa permanência totalmente implantados, e os objetivos específicos serão descrever as possíveis complicações relacionadas ao cateter, discutindo os sinais e sintomas destas complicações e descrever as ações de enfermagem para o controle destas complicações, com isto melhorando o atendimento pelo profissional ao paciente e melhorar a qualidade de vida do paciente oncológico.